| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
13.710 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
13.710 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
13.710 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CTTN |
CTTN, EMS1: Src substrate cortactin |
13.710 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
C7 |
C7: Complement component C7 precursor |
13.690 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
13.690 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
C7 |
C7: Complement component C7 precursor |
13.690 |
Evidence |
|
| MYH9 |
MYH9: Myosin-9 |
ARHGAP12 |
ARHGAP12: Rho GTPase-activating protein 12 |
13.680 |
Evidence |
|
| MSN |
MSN: Moesin |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
13.680 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
13.680 |
Evidence |
O
|
| INSR |
INSR: Insulin receptor precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
13.680 |
Evidence |
|
| FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
13.680 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
13.670 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
13.670 |
Evidence |
|
| GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
13.670 |
Evidence |
|
| TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
13.670 |
Evidence |
|
| VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
STX5A |
IPI00386786 |
13.630 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB5C |
RAB5C, RABL: Ras-related protein Rab-5C |
13.630 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
CRKL |
CRKL: Crk-like protein |
13.590 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
BMX |
IPI00514142 |
13.590 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
13.590 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
13.590 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
13.590 |
Evidence |
|
| S100B |
S100B: Protein S100-B |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
13.590 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
13.590 |
Evidence |
|